Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children

Pediatric Critical Care Medicine

Volumn 12, Issue 1, 2011, Pages 28-32

  Thomas, Christopher A ^a   Moffett, Brady S ^a   Wagner, Jeffrey L ^a   Mott, Antonio R ^a,b   Feig, Daniel I ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

hypertensive urgency; labetalol; malignant hypertension; neonate; nicardipine; nitroprusside

Indexed keywords

LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HOSPITAL BED; HUMAN; HYPERKALEMIA; HYPERTENSIVE CRISIS; HYPOGLYCEMIA; HYPOTENSION; MALE; MEDICAL RECORD REVIEW; PEDIATRIC HOSPITAL; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TEACHING; TRAUMATIC BRAIN INJURY;

EID: 78751645498     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181e328d8     Document Type: Article

References (22)

1. Temple ME, Nahata MC: Treatment of pedi-atric hypertension. Pharmacotherapy 2000; 20:140-150
2. Flynn JT, Tullus K: Severe hypertension in children and adolescents: Pathophysiology and treatment. Pediatr Nephrol 2009; 24: 1101-1112
3. Patel HP, Mitsnefes M: Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 2005; 17: 210-214
4. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(2 Suppl 4th Report):555-576
5. Flynn JT: Neonatal hypertension: Diagnosis and management. Pediatr Nephrol 2000; 14: 332-341
6. Varon J, Marik P: The diagnosis and management of hypertensive crises. Chest 2000; 118: 214-227
7. Labetalol hydrochloride injection package insert. Bedford Laboratories, June 2000
8. Neutel JM, Smith DH, Wallin D, et al: A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hyper-tens 1994; 7:623-628
9. Tenney F, Sakarcan A: Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am J Kidney Dis 2000; 35:E20
10. Milou C, Debuche-Benouachkou V, Semama DS, et al: Intravenous nicardipine as a first-line antihypertensive drug in neonates. Intensive Care Med 2000; 26:956-958
11. Flynn JT, Mottes TA, Brophy PD, et al: Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 2001; 139:38-43
12. Yang HJ, Kim JG, Lim YS, et al: Nicardipine versus nitroprusside infusion as antihyper-tensive therapy in hypertensive emergencies. J Int Med Res 2004; 32:118-123
13. Deal JE, Barratt TM, Dillon MJ: Management of hypertensive emergencies. Arch Dis Child 1992; 1089-1092
14. Immink RV, van den Born BH, van Mont-frans GA, et al: Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension. Hypertension 2008; 52:236-240
15. Bunchman TE, Lynch RE, Wood EG: Intravenously administered labetalol for treatment of hypertension in children. J Pediatr 1992; 120:140-144
16. Schwartz GJ, Brion LP, Spitzer A: the use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 1987; 34:571-590
17. Flynn TF, Tullus K: Severe hypertension in children and adolescents: Pathophysiology and treatment. Pediatr Nephrol 2009; 24: 1101-1112
18. Benedetti MS, Baltes EL: Drug metabolism and distribution in children. Fund Clin Pharmacol 2003; 17:281-299
19. Nashina K, Akamatsu H, Mikawa K, et al: A Comparison of atenolol, labetalol, esmolol, and landiolol for altering human neutrophil functions. Anesth Analg 2001; 93:641-644
20. Jivraj S, Mazer CD, Baker AJ, et al: Case report: Profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage. Can J Anaesth 2006; 53:678-683
21. Liu-DeRyke X, Janisse J, Coplin WM, et al: A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care 2008; 9:167-176
22. Wintergerst KA, Buckingham B, Gandrud L, et al: Association of hypoglycemia, hypergly-cemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179